This Is MS Multiple Sclerosis Community: Knowledge & Support

Acorda Therapeutics Inc. said Wednesday that clinical study data shows its multiple sclerosis drug Ampyra continued to help patients for up to five years.

Ampyra is used to improve the walking speed in MS patients. The company said Wednesday that the benefits of Ampyra that were observed in clinical trials continued for as much as five years in extension studies. The report was based in 483 patients who participated in a late-stage clinical trial ...

Biogen Idec Canada announces that Fampyra (fampridine sustained release tablets or fampridine SR) is now available for prescription for patients living with multiple sclerosis (MS) in Canada.

Health Canada approved Fampyra on February 10, 2012 for the symptomatic improvement of walking in adult MS patients with walking disability (EDSS 3.5-7).

Walking impairment is one of the most common and disruptive consequences of MS and Fampyra is the first approved treatment that addresses this unmet ...

Interactive website for Ampyra® (Dalfampridine) MS users launched




Acorda Therapeutics, Inc. has announced the launch of a new interactive patient website called Ampyra Journeys. The site is the first-ever stand-alone patient site to focus on walking problems associated with multiple sclerosis (MS). Ampyra (dalfampridine) is an oral medication approved by the FDA as a treatment to improve walking in patients with multiple sclerosis. This was demonstrated by an increase in walking speed.

The Ampyra ...

DEAR FRIENDS . my name is seeva from AUSTRALIA, There is a good news for m.s patients from BIOGEN AUSTRALIA. From last week BIOGIN AUSTRALIA interduced a patient access scheme for purches FAMPRYRA First prescription free of charge and if you do respond positvely to treatment, and your DR. recommends you continue with FAMPRRA, then every fourth priscription will be free of charge until FAMPYRA is listed on the PBS. You can get the first ...

HI friend my name is seeva from SYDNEY AUSTRALIA. There is a good news for m.s patients from BIOGEN AUSTRALIA. From last week BIOGIN AUSTRALIA interduced a patient access scheme for purches FAMPRYRA First prescription free of charge and if you do respond positvely to treatment, and your DR. recommends you continue with FAMPRRA, then every fourth priscription will be free of charge until FAMPYRA is listed on the PBS. You can get the first ...

I have been taking ampyra (called fampyra in Australia) since it has been available in this country in October 2011. It is costly and I have been trying to get my health fund (HCF) to recognise this medication so I can make a claim and get some reimbursement for the cost. HCF still has not given me any answer.

Has anyone else been trying to get some reimbursement for fampyra from their health fund? Any ...

Everytime I go to my Neuro, they test my walking time.
I don't feel like I have slowed at all. But he wants me to start taking this stuff. They delivered it today. With all the kidney warnings on here I am wondering if I should take it? I mean, the Rebif is supposedly bad enough on your kidneys, now I am going to strain them even more with this stuff?

Anybody have Anthem PPO who is taking Ampyra? How much is it costing you?

Id like to give it a try but I can't get an answer of how much it will cost. I was told my co-pay is 50% of the allowed rate but they won't tell me the allowed rate!

Hi, to the forum:

Has anyone been thinking of taking both AMPYRA( 4-AP) and LDN?
Does anyone know if there are contraindications?
What a dilemma*
I would love to talk about it

Regards seeva :twisted:

Fampyra (fampridine) is indicated for use in multiple sclerosis to improve walking in patients who have a walking disability (EDSS 4-7).

Pharmacology

Fampridine is a potassium channel blocker. It prolongs channel repolarisation which enhances action potential formation in demyelinated axons, leading to improved neurological function.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1310